“borderline non-significant”

Apart from the difference between standard criteria status 1 and exceptions in status 1 becoming borderline non-significant ( p = 0.053), these results were fully corroborated in the multivariable model.

A personal history of colonic lesions was associated with a numerically higher, but borderline non-significant, neoplastic lesions detection rate (OR 3.56; 95% CI, 0.98-12.90; P = .053).

Comparison between patients who received fewer than two DMTs prior to CLAD initiation compared to those who received two or more: a significant difference in duration until CDW during the study (borderline non-significant, p = 0.053).

Women also continued to show greater odds of participation than men when controlling for all other variables, although this effect was borderline non-significant (OR 1.41, 95% CI 1.00–1.99, P = 0.053).

For control participants, the borderline non-significant correlations between the difference in heterophoria at distance and near and vergence and refractive state changes were r S = 0.42 ( p = 0.053) and r S = 0.42 ( p = 0.052), respectively.

Moderate GCS impairment (9–12) showed a borderline non-significant trend (SHR 0.50, 95% CI 0.25–1.01, p = 0.053).

Kaplan–Meier analysis and Cox regression censored at 5 years showed no significant impact of p53 or HER2 on OS, except for a borderline non-significant adverse effect of the p53 null phenotype (restricted mean OS = 3.40 vs. 3.91 years, p = 0.053; HR = 1.59, 95% CIs 0.99–2.54, p = 0.055) ( Figure 6A ), and significant negative effect of the p53 null phenotype in multivariable age-adjusted Cox regression (HR = 1.61, 95% CIs 1.01–2.58, p = 0.047) ( Figure 6B ).

This difference was borderline non-significant ( p = 0.053).

A borderline non-significant time effect was observed for peripheral systolic BP ( p = 0.053) and diastolic BP was reduced over time ( p = 0.027) with a non-significant time by treatment effect ( p = 0.053).

RYGB patients had a lower 3 H-recovery than CTR, reflecting a slower transit ( p = 0.005, Figure 2 ), whereas SG did not differ from RYGB ( p = 0.665) and had a borderline non-significant difference with CTR ( p = 0.054).

an increase in male attractiveness; Dispersion: 0.333; Carbohydrate: F 1,104 = 3.044, p-value = 0.084; Table S2 ), which measures male attractiveness when focal males encounter an unreceptive females; there was also a borderline non-significant interaction protein*carbohydrate on the latency of females to mate with the focal male (Protein*Carbohydrate: F 1,99 = 3.799, p-value = 0.054, Table S2 ).

AD 858.4 [694.7–1171.5], p <0.001) and borderline non-significant for PH ( p =0.054).

Phage composition showed a borderline non-significant difference between responders and non-responders following FMT (pairwise PERMANOVA p = 0.054, Fig. 6B , Supplementary Fig. 7A ).

There was also a borderline non-significant interaction Male strain × Female strain on offspring production (Male strain × Female strain: F 1,71 = 3.813, p = 0.054), where mating pairs with LP -infected males and AP ­-infected females had higher short-term offspring production ( figure 2 b ; see the electronic supplementary material for full analysis).

This relationship was significant for both the single and the repeated annual cycle (Tables 1 , 2 ) and borderline non-significant ( p = 0.054) during breeding (Table 3 ).

As reported in Table 1 , the percentage change in TEED from baseline to the last follow-up is significant in female patients (97.4 ± 241.1%, p ≤ 0.000), whereas in male patients the change is borderline non-significant (33.2 ± 404.3%, p = 0.054) after multiple comparison correction.

However, when TOP2A amplification and CEP17 duplication were combined, Kaplan-Meier and log-rank analyses showed a significant association with better DFS ( P = .026) and a borderline non-significant trend with OS ( P = .054; Figure 1 ).

Although borderline non-significant ( χ 2 test, P = 0.054), a higher percentage of patients with metastatic lymph nodes were identified in the MDACC cohort (i.e. 16% MDACC vs. 8.5% Bergen cohort).

Additionally, total sperm count was higher in protocol 1, with a borderline non-significant difference ( p = 0.054).

Trim-and-fill imputed no missing studies for baseline FVC and one study for baseline DLCO; the adjusted pooled estimates for FVC became borderline non-significant ( p = 0.055), whereas the DLCO association remained significant after adjustment.

The implant location was borderline non-significant for postoperative infection ( p = 0.055).

The GISIS group had, on average, twice the total volume of secretions suctioned per patient compared with the GEvac group (26 ± 19 mL from 10 patients vs 13 ± 10 mL from 12 patients), but the result was borderline non-significant ( P = 0.055) ( Table 4 ).

Notably, at the early time point, richness was also increased in T2DM compared to controls with corresponding increases in the Shannon index; however, this was borderline non-significant ( P =0.055, Fig. 3a, b ).

The LS extension difference between the two strains is borderline non-significant (Non-parametric Mann-Whitney Test; P = 0.055).

We observed no association between APOE e4 + ( B = − 3.52 [− 7.84–0.80], p = 0.108) or BDNF Met + ( B = 3.78 [− 0.84–8.40], p = 0.107) and the BAI score and a borderline non-significant association between APOE*BDNF interaction ( B = − 9.29 [− 18.78–0.20], p = 0.055) and the BAI score.